Skip to main content
MEDS logo

MEDS · Wellgistics Health, Inc.

$3.15 -0.40 (-11.27%) At close · Jul 29
Market Cap
$446.13M
Shares
125.67M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.55 Open$3.18 Day$3.04–3.88 52W$2.49–97.50 Avg vol 30d43K Short int70K · 0.1% float · 4.5d Short vol41% DataFeb 2025–Jul 2026 Filing10-Q · May 19

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 19, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −75%
below
Price vs 50-day avg −4%
below
RSI (14) 55
neutral
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +21%
trailing
6-month return −80%
trailing
YTD return −82%
this year
Relative strength −88%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $14 — 200d above 50d
Institutional flow Distributing
2 of 13 funds reported for Jun 30 · net -590 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.06% of float · ▼ -33.7% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
13 holders — mid 1-yr range
Squeeze score 28
low risk · 0–100
Fundamentals
Weak
Revenue growth +29%
Y/Y
Gross margin -28%
contracting
EPS growth −853%
Y/Y
Balance sheet $23.4M
net debt
Quant / Vol
risk profile
Very High
Volatility 266%
annualized · 1-yr
Max drawdown −97%
past year
ATR 12.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed May 19, 2026
Revenue · Q2-2026 Initiated $1.78M
prior qtr $1.56M midpoint +13.8% QoQ

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−75% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
55 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $4 › 200d $14 — 200d above 50d
Institutional flow Distributing
2 of 13 funds reported for Jun 30 · net -590 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.06% of float · ▼ -33.7% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
13 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $2 Now $4 · 1% 52-wk high $98
vs 200-day avg -75% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Distribution — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MEDS
Wellgistics Health, Inc.
this stock
$446.13M -82.3% +0.0% 0.1%
MCK
Mckesson Corp
$106.92B +8.5% +3.1% 23.2 3.2%
COR
Cencora, Inc.
$62.18B -5.2% +9.3% 24.5 3.0%
CAH
Cardinal Health Inc
$54.71B +13.7% -1.9% 2.9%
HSIC
Henry Schein Inc
$9.76B +13.6% +5.9% 25.9 5.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
13
% held
0.0%
Reported
2 of 13
Top holder
GEODE CAPITAL MANAGEMENT,…
Held Float
View
Held by Funds
Fund positions
8
View
Short & Settlement
Short Interest Falling
Shares short
69.7K
Days to cover
4.5d
Change
-35.5K sh
View
Short Volume
Short vol %
41%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
1.9K
Value
$5.4K
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$23.3M
Net income (FY)
$-101.3M
EPS diluted
$-71.50
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 29, 2026
This year
28
View

Performance

5D 20D 120D MTD YTD
MEDS +0.9% +21.2% -80.4% +14.5% -82.3%
SPY -1.0% 0.0% +7.4% -0.8% +8.6%
vs SPY +1.8% +21.2% -87.8% +15.3% -90.9%
Key facts CIK 2030763 CUSIP 949503205 13F (30d) 1 filings 1 filers Visit website